Crescita Therapeutics Inc. (CTX:ASX) Investor Relations Material

Overview

Crescita is a Canadian commercial dermatology company with a focus on growth and innovation. They have their own research and development and manufacturing capabilities and offer a range of non-prescription and prescription skincare products. The company has proprietary drug delivery platforms, which enable them to formulate patented products that deliver active ingredients into or through the skin. Crescita is listed on both the Toronto Stock Exchange and the OTC US exchange.

Frequently Asked Questions

What is Crescita Therapeutics Inc.'s ticker?

Crescita Therapeutics Inc.'s ticker is CTX

What exchange is Crescita Therapeutics Inc. traded on?

The company's shares trade on the ASX stock exchange

Where are Crescita Therapeutics Inc.'s headquarters?

They are based in Sydney, New South Wales

How many employees does Crescita Therapeutics Inc. have?

There are 5001-10,000 employees working at Crescita Therapeutics Inc.

What is Crescita Therapeutics Inc.'s website?

It is http://www.crescitatherapeutics.com/

What type of sector is Crescita Therapeutics Inc.?

Crescita Therapeutics Inc. is in the Basic Materials sector

What type of industry is Crescita Therapeutics Inc.?

Crescita Therapeutics Inc. is in the Oil & Gas Refining & Marketing industry

Who are Crescita Therapeutics Inc.'s peers and competitors?

The following five companies are Crescita Therapeutics Inc.'s industry peers:

- Phillips 66

- Crescita Therapeutics Inc.

- DCC plc

- Valvoline

- Phillips 66 Partners LP